Contact information Verified work emails, personal emails, and direct dials — unlocked in one click.
Work email
•••••@oisinbio.com
Personal email
•••••@•••••.com
Direct dial
+•• ••• ••• ••••
Free to start · No credit card required
Current company Oisin Biotechnologies
Biotechnology Research · 17 employees · Founded 2014 · Seattle, Washington, United States
Oisín Biotechnologies is developing a new class of genetic medicines that target the biology of aging. We don\'t make pills or supplements; we build powerful, redosable genetic therapies and start with indications regulators already understand, so we can attack the mechanisms of age-related decline on a path that leads to approval. Our therapies are built on the Fusogenix Proteo-Lipid Vehicle (PLV), a non-viral delivery technology that fuses directly with target-cell membranes to deliver both DNA and RNA payloads. Delivery has been the Achilles\' heel of genetic medicine. Viral approaches can\'t be safely redosed, carry limited payloads, and struggle to reach tissues beyond the liver. Fusogenix PLV combines the efficiency of viral delivery with the safety and scalability of non-viral systems. Oisín has a growing pipeline that applies one delivery platform across aesthetic and longevity medicine. Targeted fat removal. A precision therapy that selectively eliminates unwanted fat while sparing surrounding tissue — body contouring through a hypodermic needle rather than surgery. Applications span rare disease and the large and growing market for non-invasive fat reduction. Muscle building. Genetic therapies that drive targeted growth and preservation of skeletal muscle. Local applications in aesthetic muscle building establish the foundation for systemic therapies that combat the loss of strength and independence that comes with age. Longevity biology. A deeper pipeline targeting the fundamental drivers of aging including klotho and other longevity-associated factors, extracellular-matrix remodeling, mitochondrial function, cellular reprogramming, and clearance of senescent cells.